Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Urologic Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Obesity 1Neuromuscular Blockade 1

Interventions

Metformin 7Exenatide 4Vitamin D 2Sugars 2Resistance Training 2penclomedine 1licogliflozin 1exemestane 1dapagliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Weight Reduction Programs 1Therapeutics 1Testosterone 1Taxes 1Tamoxifen 1TOPS 1Surveys and Questionnaires 1Sugammadex 1Sodium-Glucose Transporter 2 Inhibitors 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Qsymia 1Progesterone 1Paclitaxel 1Observation 1Nutrition Assessment 1Naltrexone 1Methods 1Letrozole 1Jogging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Obesity × Sugammadex × Clear all
NCT03196791 2021-07-12

Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

Korea University Anam Hospital

Phase 3 Completed
196 enrolled 11 charts
GastrointestinalOther

Obesity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡